The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doyle Thomas James since 2023.
This trader's CIK number is 1910331.
At the time of last reporting, Doyle Thomas James was the SVP, Finance & Accounting of Kura Oncology, Inc.. (stock ticker symbol KURA).
Also see all insider trading activities at Kura Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KURA | 0 | $0 | 4,949 | $38,958 | 0 | $0 |
| 2024 | KURA | 0 | $0 | 2,318 | $41,262 | 0 | $0 |
| 2023 | KURA | 0 | $0 | 1,548 | $21,501 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-28 | KURA | Sale | 4,949 | 7.87 | 38,958 |
| 2024-01-29 | KURA | Sale | 2,318 | 17.80 | 41,262 |
| 2023-01-27 | KURA | Sale | 1,548 | 13.89 | 21,501 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doyle Thomas James (SVP, Finance & Accounting of Kura Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.